Ontrak Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Ontrak şirketinin toplam hissedar öz sermayesi $11.5M ve toplam borcu $7.9M olup, bu da borç-öz sermaye oranını 69.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $22.4M ve $10.9M dir.

Anahtar bilgiler

69.1%

Borç/özkaynak oranı

US$7.92m

Borç

Faiz karşılama oranı	n/a
Nakit	US$7.97m
Eşitlik	US$11.46m
Toplam yükümlülükler	US$10.94m
Toplam varlıklar	US$22.40m

Son finansal sağlık güncellemeleri

Recent updates

Slammed 26% Ontrak, Inc. (NASDAQ:OTRK) Screens Well Here But There Might Be A Catch

Sep 25

Newsflash: Ontrak, Inc. (NASDAQ:OTRK) Analysts Have Been Trimming Their Revenue Forecasts

Aug 18

Ontrak Non-GAAP EPS of -$0.63 misses by $0.10, revenue of $3.9M misses by $0.75M

Aug 09

Ontrak CMO Robert Accordino to depart, Judith Feld to succeed

Jul 26

Is Ontrak (NASDAQ:OTRK) Using Too Much Debt?

Feb 23

Ontrak Preferred Stock: 20%+ Yield And Potential 150% Return In One Year

Jan 24

Ontrak: Why You Should Buy The Dip

Oct 21

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: OTRK 'nin kısa vadeli varlıkları ( $10.2M ) kısa vadeli yükümlülüklerini ( $8.7M ) aşıyor.

Uzun Vadeli Yükümlülükler: OTRK şirketinin kısa vadeli varlıkları ( $10.2M ) uzun vadeli yükümlülüklerini ( $2.3M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: OTRK şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: OTRK şirketinin 5 yıl önce negatif özkaynağı vardı, ancak şu anda pozitif ve dolayısıyla iyileşme kaydetti.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: OTRK şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: OTRK un, serbest nakit akışı her yıl % 11.1 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Ontrak Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Ontrak to Implement 1-for-15 Reverse Split to Regain Compliance with the Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market, Effective September 23, 2024

Ontrak, Inc. announced delayed annual 10-K filing

Ontrak, Inc. announced delayed 10-Q filing

Ontrak, Inc. Receives Non-Compliance Letter from Nasdaq

Ontrak Receives Non-Compliance Notice from Nasdaq

Ontrak Announces 1-for-6 Reverse Split Primarily Intended to Bring the Company into Compliance with Nasdaq’s Minimum Bid Price Requirement

Recent updates

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Ontrak, Inc. Provides Revenue Guidance for the Quarter Ending December 31, 2024

New major risk - Revenue and earnings growth

Ontrak, Inc. to Report Q3, 2024 Results on Nov 13, 2024

Slammed 26% Ontrak, Inc. (NASDAQ:OTRK) Screens Well Here But There Might Be A Catch

Ontrak to Implement 1-for-15 Reverse Split to Regain Compliance with the Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market, Effective September 23, 2024

New major risk - Market cap size

Second quarter 2024 earnings released: US$0.19 loss per share (vs US$1.84 loss in 2Q 2023)

New major risk - Revenue and earnings growth

Ontrak, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Ontrak, Inc., Annual General Meeting, Sep 10, 2024

Ontrak, Inc. Adopts Comprehensive Healthcare Integration (CHI) Framework to Enhance Care Delivery

A Piece Of The Puzzle Missing From Ontrak, Inc.'s (NASDAQ:OTRK) Share Price

Price target decreased by 78% to US$4.00

Ontrak Launches Mental Health Digital Twin Technology, Revolutionizing Precision Mental Healthcare Delivery

Ontrak, Inc. Provides Revenue Guidance for the Quarter Ending June 30, 2024

Ontrak, Inc. to Report Q1, 2024 Results on May 14, 2024

Ontrak, Inc. Provides Revenue Guidance for the Quarter Ended March 31, 2024

Ontrak, Inc. to Report Q4, 2023 Results on Apr 16, 2024

The Market Lifts Ontrak, Inc. (NASDAQ:OTRK) Shares 206% But It Can Do More

Ontrak, Inc. announced delayed annual 10-K filing

Ontrak Health Announces the Launch of the Ontrak Advanced Engagement System, Ushering in the Next Era of Ai-Enabled Behavioral Healthcare

Investors Give Ontrak, Inc. (NASDAQ:OTRK) Shares A 33% Hiding

Price target decreased by 78% to US$4.00

No longer forecast to breakeven

Ontrak, Inc. announced delayed 10-Q filing

New major risk - Shareholder dilution

Ontrak, Inc. Reaffirms Revenue Guidance for the Year Ending December 31, 2023

New major risk - Share price stability

Ontrak, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Ontrak Health Announces Promising Results of Formal Evaluation Conducted on Ontrak WholeHealth+ Program

Ontrak, Inc. Receives Non-Compliance Letter from Nasdaq

Ontrak Health's Study of Behavioral Health Patient Reports Outcomes Reveals 53-60% Reduction in Anxiety and Depressive Symptoms

Ontrak, Inc., Annual General Meeting, Sep 28, 2023

Ontrak Receives Non-Compliance Notice from Nasdaq

First quarter 2023 earnings released: US$2.26 loss per share (vs US$4.89 loss in 1Q 2022)

New major risk - Market cap size

Ontrak Health Announces Breakthrough Increase in Behavioral Health Diagnoses

Ontrak Announces 1-for-6 Reverse Split Primarily Intended to Bring the Company into Compliance with Nasdaq’s Minimum Bid Price Requirement

Ontrak, Inc. to Report Q2, 2023 Results on Aug 09, 2023

First quarter 2023 earnings released: US$0.38 loss per share (vs US$0.81 loss in 1Q 2022)

Ontrak, Inc. Provides Revenue Guidance for the Year Ending December 31, 2023

Full year 2022 earnings released: US$2.60 loss per share (vs US$2.47 loss in FY 2021)

Ontrak, Inc. announced delayed 10-Q filing

Price target increased to US$2.50

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Ontrak, Inc. Provides Revenue Guidance for the Year Ending December 31, 2022

Ontrak, Inc. to Report Q3, 2022 Results on Nov 09, 2022

Ontrak Receives Letter from Nasdaq Regarding Non-Compliance with Minimum Bid Price Requirement

Price target increased to US$2.50

Ontrak, Inc. Names James Messina to its Board of Directors

Ontrak, Inc. Announces Board Changes

Newsflash: Ontrak, Inc. (NASDAQ:OTRK) Analysts Have Been Trimming Their Revenue Forecasts

Consensus revenue estimates fall by 25%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Ontrak, Inc. Provides Revenue Guidance for the Year Ending December 31, 2022

Ontrak Non-GAAP EPS of -$0.63 misses by $0.10, revenue of $3.9M misses by $0.75M

Insufficient new directors

Ontrak, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Ontrak, Inc. Announces Executive Changes

Ontrak CMO Robert Accordino to depart, Judith Feld to succeed

Ontrak, Inc., Annual General Meeting, Jul 29, 2022

Ontrak, Inc. Announces Resignation of Robert Accordino as Chief Medical Officer, Effective July 29, 2022

Price target decreased to US$2.33

Ontrak, Inc. Announces Promotion of Executives

Ontrak, Inc. Announces Board Changes

Ontrak, Inc. Provides Revenue Guidance for the Year Ending December 31, 2022

Ontrak, Inc. announced delayed annual 10-K filing

Consensus revenue estimates fall by 47%